EXAS vs OPY · rev $2.76B vs P/E 13, rev $1.43B
EXACT Sciences Corporation (EXAS) versus Oppenheimer Holdings Inc (OPY) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
EXAS currently screens at market cap $20.03B. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Not investment advice. Open the EXAS and OPY stock pages for the full models.
Not investment advice.